Optimal care for hepatitis virus–related hepatocellular carcinoma (HCC) would include eradication of tumor and elimination of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Accomplishing these goals could prevent deaths from cancer or cirrhosis and reduce the likelihood of viral transmission. Tremendous progress has recently been achieved for tumor and antiviral therapies. Long-term survival from cancer was previously a rarity. Now, partial hepatectomy, liver transplant, or tumor ablation provide 5-year survival rates of 45% to 80%.1 Direct-acting antivirals (DAA) can now prevent cirrhosis in patients with HBV and can produce cures in patients with HCV2 for most patients and with little morbidity. Data are also accumulating that successful antiviral treatment reduces recurrence of cancer. In this issue of JAMA Surgery, Li et al3 examined a cohort of 2552 patients with resection of HCC and demonstrated that preresection (>90 days) effective treatment for HBV is associated with a lower tumor vascular invasion and decreased recurrence.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Fong Y. Combining Antiviral Therapy With Tumor Resection as Optimal Treatment for Hepatocellular Carcinoma. JAMA Surg. 2018;153(10):e182728. doi:10.1001/jamasurg.2018.2728
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: